Therapeutic efficacy of DNA encoding IFN-α1 against corneal HSV-1 infection

Current Eye Research

Volumn 20, Issue 5, 2000, Pages 405-412

  Noisakran, S ^a   Carr, D J J ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Gene therapy; HSV 1; Interferon alpha

Indexed keywords

ALPHA1 INTERFERON; PLASMID DNA; PLASMID VECTOR; PROTEIN P27; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC CODE; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; KERATITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TRANSGENE; TREATMENT OUTCOME; TRIGEMINUS GANGLION; VIRUS CULTURE; VIRUS GENE; VIRUS LOAD; VIRUS REPLICATION;

EID: 0033861966     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/0271-3683(200005)2051-1FT405     Document Type: Article

References (49)

1. Herpes simplex viruses
2. Regulation of herpesvirus macromolocular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins
3. Regulation of herpesvirus macromolecular synthesis: Sequential transition of polypeptide synthesis requires functional viral polypeptides
4. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection
5. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea
6. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1
7. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1
8. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection
9. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis
10. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis
11. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas
12. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1
13. The interferons: Mechanisms of action and clinical applications
14. Endogenously produced interferon α protects mice from herpes simplex virus type 1 corneal disease
15. Immunization with HSV-1 antigen rapidly protects against HSV-1-induced encephalitis and is IFN-γ independent
16. Astrocytes targeted expression of interferon-α1 protects mice from acute ocular herpes simplex virus type 1 infection
17. Antiviral activities of individual murine IFN-α subtypes in vivo: Intramuscular injection of IFN expression constructs reduces cytomegalovirus replication
18. Ectopic expression of DNA encoding IFN-α1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis
19. Nonspecific host responses to viral infections
20. Interferons in host defense
21. Interferon inhibits onset of herpes simplex virus immediate-early transcription
22. Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages
23. Formation. of non-infective herpesvirus particles in cultured cells treated with human interferon
24. Interferon in treatment of dendritic keratitis in humans: A preliminary report
25. Human leukocyte interferon for the prevention of recurrences of herpetic keratitis
26. Herpes simplex type 1 ICP27 is an essential regulatory protein
27. Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes
28. Shuttling of the herpes simplex virus 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins
29. The herpes simplex virus immediate-early protein ICP27 shuttles between nucleus and cytoplasm
30. The herpes simplex virus regulatory protein ICP27 contributes to he decrease in cellular mRNA levels during infection
31. Herpes simplex virus IE63 acts at the posttranscriptional levels to stimulate viral mRNA 3' processing
32. A herpes virus regulatory protein appears to act posttranscriptionally by affecting mRNA processing
33. Herpes simplex virus inhibits host cell splicing and the regulatory protein ICP27 is required for this effect
34. Regulation of herpes simplex virus type 1 poly(A) site usage and the action of the immediate-early protein IE63 in the early-late switch
35. Herpes simplex virus type 1 protein IE63 affects the nuclear export of virus intron-containing transcripts
36. The herpes simplex virus 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells
37. HSV-1 thymidine kinase promotes virulence and latency in the mouse
38. A low thymidine kinase-producing mutant of herpes simplex virus type causes latent trigeminal ganglia infections in mice
39. Neurovirulence of herpes simplex virus type 1 depends on age in mice and thymidine kinase expression
40. IFN-α1 plasmid construct affords protection against HSV-1 infection in transfected L929 fibroblasts
41. The role of natural killer cells in viral infection
42. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
43. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin-12, and interferon γ
44. The immunologic properties of DNA
45. Gene vaccination: Plasmid DNA is more than just a blueprint
46. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations
47. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously
48. The influence of lipofectin on the in vitro stimulation of murine spleen cells by bacterial DNA and plasmid DNA vectors